Keyword search
Filter results by
Search HelpKeyword(s)
Subject
Survey or statistical program
Results
All (2)
All (2) ((2 results))
- 1. Use of biotechnology in Canadian industry ArchivedArticles and reports: 88-003-X20020016152Geography: CanadaDescription:
The Biotechnology Use & Development Survey-1999 provides insights into the transition from R&D to the commercial use of a technology in products and processes. Improvement in product quality is reported as the number one benefit derived from using biotechnologies. This article explores some of the characteristics of the firms that use biotechnologies addressing the questions: "Why use biotechnology?" and "Why not use biotechnology?"
Release date: 2002-02-15 - Articles and reports: 88-003-X20000035772Geography: CanadaDescription:
Technological change and innovations depend greatly on R&D activities and investments. R&D is concentrated around the "core firms" that are responsible for 87% of expenditures. Biotechnology R&D performers accounted for $904 million of R&D expenditure. Biotechnology R&D is concentrated in large firms with 75% of R&D occuring in firms with 100 or more employees. Almost 77% of funding sources for R&D in biotechnology came from the private sector and 21% from foreign sources.
Release date: 2000-10-06
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (2)
Analysis (2) ((2 results))
- 1. Use of biotechnology in Canadian industry ArchivedArticles and reports: 88-003-X20020016152Geography: CanadaDescription:
The Biotechnology Use & Development Survey-1999 provides insights into the transition from R&D to the commercial use of a technology in products and processes. Improvement in product quality is reported as the number one benefit derived from using biotechnologies. This article explores some of the characteristics of the firms that use biotechnologies addressing the questions: "Why use biotechnology?" and "Why not use biotechnology?"
Release date: 2002-02-15 - Articles and reports: 88-003-X20000035772Geography: CanadaDescription:
Technological change and innovations depend greatly on R&D activities and investments. R&D is concentrated around the "core firms" that are responsible for 87% of expenditures. Biotechnology R&D performers accounted for $904 million of R&D expenditure. Biotechnology R&D is concentrated in large firms with 75% of R&D occuring in firms with 100 or more employees. Almost 77% of funding sources for R&D in biotechnology came from the private sector and 21% from foreign sources.
Release date: 2000-10-06
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: